ARCHIVES

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987

Expiring Program Offer Flexibility

February 12, 1982

Marc Lippman To Leave Georgetown For Michigan To Head Internal Medicine; Five Named To DCLG.

September 15, 2000

NCI-Approved Trials Listed

April 28, 2006